Objective
Common allergic disease has trebled in the last twenty years, resulting in approximately one-fifth of the EU population likely to be seeking treatment for allergy. Potentially life-threatening conditions such as peanut allergy now affect about one in 70 children and are still increasing.
Asthma, rhinitis and eczema have increased two- to three-fold in the last twenty years. The cytokine IL12 is one of the most powerful Th1 lymphokines and it has been found to cure Th2 cytokine-mediated murine schistosomias is and to inhibit allergic airway responses in a mouse model of asthma. IL12 has also been shown to be involved in protection against bacterial and parasitic infection as well as displaying anti-tumour activity.
The objective of this proposal is to engineer recombinant strains of the food grade bacterium Lactococcus lactis capable of secreting IL12 and to develop this as an alternative delivery vehicle for cytokine administration. We plan to use an existing allergy mouse model to test the effectiveness of the recombinant L.lactis in inducing IL12 response and alleviation of allergic disease.
This is a multidisciplinary project which will provide the Marie Curie Fellow with research training in modern molecular genetics of lactic acid bacteria as well as complementary skills the use of animal mode, protein analysis, immunochemistry and cytokine analysis.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine pneumology asthma
- natural sciences chemical sciences organic chemistry organic acids
- natural sciences biological sciences microbiology bacteriology
- medical and health sciences clinical medicine dermatology
- medical and health sciences clinical medicine allergology
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2002-MOBILITY-5
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.